1Department of Pharmacy Practice, National Institute of Pharmaceutical Education and Research, Mohali, India.
2Department of Endocrinology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Copyright © 2015 Korean Diabetes Association
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.
Values are presented as mean±standard deviation.
BMI, body mass index; WC, waist circumference; SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1c, glycosylated hemoglobin; TC, total cholesterol; HDL-C, high density lipoprotein cholesterol; LDL-C, low density lipoprotein cholesterol; TG, triglycerides.
aP value indicates the comparison between males and females where continuous variables assessed using unpaired t-test and categorical variables were assessed using chi-square test.
FRS assessment | UKPDS assessment | |
---|---|---|
Not high risk | High risk | |
Not high risk | 341 (69.7) | 46 (9.4) |
High risk | 42 (8.6) | 60 (12.3) |
Values are presented as number (%) or mean±standard deviation.
FRS, Framingham Risk score; UKPDS, United Kingdom Prospective Diabetes Study.
aP value indicates the comparison between males and females, where continuous variables are expressed in mean±standard deviation and assessed using unpaired t-test and categorical variables were expressed in percentages and assessed using chi-square test.